Why the future of treating redness may be less about correcting the skin—and more about helping it recover
In aesthetic medicine, we are trained to correct.
Pigmentation? Treat it. Texture? Resurface it. Vessels? Target them. Aging? Stimulate collagen.
But rosacea forces us to think differently.
When skin is chronically red, reactive, burning, or intolerant, aggressive correction can become part of the problem. The treatment itself may generate inflammation, disrupt an already fragile barrier, and trigger the very redness we are trying to control.
For me, this makes rosacea one of the clearest examples of where regenerative aesthetics needs a different philosophy: stabilize first, regenerate second, and correct only when the skin is ready.
Contribution by Dr. Alberto Leguina
Dr. Alberto Leguina-Ruzzi is a Biologist, Doctor of Medical Sciences, Physician, and Dermatology Specialist with more than a decade of experience across biomedical research, university teaching, clinical practice, and the pharmaceutical industry.
He currently serves as President of the Chilean Chapter of ISWAM (International Seminar and Workshop in Aesthetic Medicine) and has shared his expertise on stages around the globe—including IMCAS, MEIDAN, SOCHIMCE, AIDA, and 5-CC, among other major international congresses.
Throughout his career, Dr. Alberto has led continuing medical education initiatives, offered scientific and technical support to sales teams, and ensured the ethical, accurate, and clinically relevant communication of medical and pharmaceutical innovations.
Rosacea Is More Than Redness
We once thought of rosacea predominantly as a vascular problem. Today, we know the picture is considerably more complicated.
Rosacea involves an interaction between vascular hyperreactivity, altered innate immunity, neurogenic inflammation, microorganisms such as Demodex, environmental triggers, and impairment of the epidermal barrier.
That last element deserves much more attention in aesthetic practice.
Research has demonstrated increased transepidermal water loss, reduced hydration and significant abnormalities of barrier function in rosacea skin. In practical terms, this helps explain something patients tell us constantly: “Everything irritates my skin.”
When the barrier is compromised, seemingly harmless cosmetics, active ingredients, temperature changes, and procedures may suddenly produce stinging, burning, or prolonged redness.
This creates a vicious circle:
Barrier damage → increased sensitivity → inflammation → vasodilation → further barrier dysfunction.
Breaking that cycle should be one of our first therapeutic objectives.
The Problem With Simply Prescribing Another Cream
Topical therapy remains an essential component of rosacea management. Depending on the clinical presentation, established treatments include ivermectin, metronidazole, and azelaic acid for inflammatory lesions, while agents such as brimonidine or oxymetazoline can reduce persistent erythema.
They work. But rosacea is rarely quite that simple.
Patients frequently present with several problems simultaneously: redness, telangiectasia, papules, burning, dehydration, and extreme sensitivity. One medication cannot necessarily address all of them.
Then there is adherence.
Rosacea treatments may themselves cause dryness, burning, or irritation, particularly in already reactive skin. Complex routines also reduce compliance. In one clinical study using electronic monitoring, average adherence to topical ivermectin over three months was only 62%.
So the question is no longer simply, “Which topical should I prescribe?”
It should be:
“What combination of medical treatment, barrier restoration, lifestyle management, and carefully selected procedures gives this particular skin the best chance of becoming stable?”
That is where regenerative aesthetics becomes particularly interesting.
My Regenerative Road Map for Rosacea
I approach reactive skin as a sequence rather than a collection of procedures.
STEP 1 — CONTROL
The first step in the Regenerative Road Map for Rosacea is to identify what is driving the disease.
Inflammatory papules and pustules, persistent erythema, telangiectasia and ocular symptoms require different strategies. Medical therapy remains fundamental, and aesthetic procedures should never replace appropriate dermatological treatment.
At the same time, simplify the patient’s skincare. Gentle cleansing, moisturisation and daily photoprotection are not optional extras—they are part of rosacea treatment.
The objective at this stage is simple: stop provoking the skin.
STEP 2 — REPAIR
Step 2 in the Regenerative Road Map for Rosacea – once inflammation is controlled, attention turns towards the barrier.
This is where regenerative aesthetics should differ fundamentally from aggressive rejuvenation.
Reactive skin does not necessarily need stronger stimulation. It needs a healthier environment in which keratinocytes, extracellular matrix, vascular structures, and immune signaling can return towards homeostasis.
Hydration, barrier-supportive skincare and carefully selected non-irritating treatments therefore become central.
I often explain this to patients using an analogy: if the roof of your house is leaking, repeatedly repainting the walls will not solve the problem. Repair the roof first.
STEP 3 — REGENERATE
Step 3 in the Regenerative Road Map for Rosacea – Only then should we ask whether an injectable or device-based intervention can improve what topical therapy has not adequately corrected.
Vascular lasers and intense pulsed light have established roles, particularly for persistent erythema and telangiectasia. A recent meta-analysis supports both IPL and pulsed-dye laser as useful modalities for rosacea.
But devices are not the only possibility.
Mesotherapy is particularly interesting because instead of simply destroying or suppressing a visible target, we may be able to influence the biological environment of the skin.
This concept became the basis of a study I published in 2025.
What We Found When We Added Mesotherapy
Our research evaluated patients with rosacea who were already receiving conventional topical treatment with ivermectin, metronidazole, and photoprotection but had not achieved satisfactory improvement.
Instead of replacing their medical treatment, we added a regenerative intervention.
Twenty patients received three monthly sessions of mesotherapy containing 1.1% high-molecular-weight non-cross-linked hyaluronic acid combined with 1.6% succinic acid, while a control group continued conventional topical management.
After three sessions, we observed:
80% reduction in baseline erythema
30% improvement in skin hydration
20% reduction in facial telangiectasia
The treatment was also less expensive than three sessions of laser therapy within the private healthcare setting evaluated in our study.
Perhaps the most important message, however, is not the percentages.
It is the therapeutic philosophy behind them.
We were not attempting to replace ivermectin, metronidazole, sunscreen, or established rosacea management. Mesotherapy was an adjunct.
That distinction is essential.
Regenerative aesthetics works best in inflammatory skin disease when it becomes part of comprehensive management rather than competing with conventional medicine.
STEP 4 — CORRECT WHAT REMAINS
Step 4 in the Regenerative Road Map for Rosacea – Once the inflammatory and barrier environment has improved, residual problems can be treated much more selectively.
Persistent vessels may benefit from vascular laser or IPL. Texture and ageing can be addressed cautiously. Pigmentation can be managed without immediately reaching for the most aggressive resurfacing protocol.
This is also where practitioners need to resist the temptation to treat every visible abnormality during the same appointment.
For reactive skin, treatment tolerance is itself a clinical outcome.
A dramatic procedure followed by weeks of inflammation is not necessarily superior to several gentler interventions that progressively improve skin quality without provoking a flare.
STEP 5 — LOOK BEYOND THE FACE
Step 5 in the Regenerative Road Map for Rosacea. Perhaps one of the most fascinating developments in rosacea research is that the story may not end at the skin.
The gut–skin axis is receiving increasing attention.
Rosacea has been associated with gastrointestinal conditions, and research is exploring relationships involving intestinal dysbiosis, small intestinal bacterial overgrowth, and other alterations of the microbiome.
A 2025 review examining diet and probiotics concluded that growing evidence supports involvement of the gut microbiota in rosacea, although we still do not have enough high-quality evidence to prescribe a universal “rosacea diet” or probiotic protocol.
That distinction matters.
We should educate patients, not sell certainty where science has not yet provided it.
What we can do is discuss individual triggers. Alcohol, heat, UV exposure, spicy foods, stress and particular foods can provoke symptoms in some patients. Keeping a trigger diary can be considerably more useful than handing everyone the same restrictive diet.
Patients with relevant gastrointestinal symptoms should also be appropriately assessed rather than simply being told that their skin problem originates in their gut.
The Most Powerful Treatment May Be Education
Rosacea is chronic. This changes the conversation.
Patients often arrive expecting us to “remove” the redness. Instead, we need to explain that successful management is usually about maintaining the skin within a more stable biological range.
Teach patients to recognize their triggers.
Teach them why sunscreen matters.
Teach them why adding five new active ingredients at the same time is a terrible experiment for reactive skin.
Teach them that a flare does not necessarily mean that every treatment has failed.
And perhaps most importantly, teach them that healthy skin does not have to be constantly stimulated.
From Correction to Resilience
In the Regenerative Road Map for Rosacea – Regenerative aesthetics is often presented through the language of stimulation: stimulate collagen, stimulate fibroblasts, stimulate repair.
Rosacea reminds us that regeneration can also mean restraint.
Sometimes the smartest intervention is the one that reduces biological stress rather than adding more of it.
My practical road map is therefore:
CONTROL → REPAIR → REGENERATE → CORRECT → MAINTAIN
Control active disease.
Repair the barrier.
Introduce regenerative treatments carefully.
Correct residual vascular or aesthetic concerns selectively.
Maintain the result through skincare, photoprotection, lifestyle education, and long-term medical follow-up.
For practitioners working with sensitive and reactive skin, this represents an important shift in thinking.
The goal is no longer to see how much correction the skin can tolerate.
The goal is to create skin that no longer needs to fight everything we do to it.
References:
Kang CN, Shah M, Tan J. Rosacea: An Update in Diagnosis, Classification and Management. Skin Therapy Lett. 2021;26(4):1-8.
Medgyesi B, Dajnoki Z, Béke G, et al. Rosacea Is Characterized by a Profoundly Diminished Skin Barrier. J Invest Dermatol. 2020;140(10):1938-1950.e5. doi:10.1016/j.jid.2020.02.025
Manfredini M, Barbieri M, Milandri M, Longo C. Probiotics and Diet in Rosacea: Current Evidence and Future Perspectives. Biomolecules. 2025;15(3):411. Published 2025 Mar 13. doi:10.3390/biom15030411
Leguina-Ruzzi A, Navarro A, Zambrano M. Efficacy and Effectiveness of High Molecular Weight Non-Cross-Linked Hyaluronic Acid Plus Succinic Acid Mesotherapy in Rosacea as Adjunct Therapy. J Cosmet Dermatol. 2025;24(10):e70484. doi:10.1111/jocd.70484